DD
The startup has developed an epigenetic testing platform that analyzes stress patterns and hormonal changes to predict and diagnose postpartum depression (PPD) before symptoms appear. By identifying at-risk individuals early, the platform enables healthcare providers to implement preventive care strategies during pregnancy or shortly after childbirth.
Updated 2 months ago
Funding
$3.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed an epigenetic testing platform that analyzes stress patterns and hormonal changes to predict and diagnose postpartum depression (PPD) before symptoms appear. By identifying at-risk individuals early, the platform enables healthcare providers to implement preventive care strategies during pregnancy or shortly after childbirth.